UPB Relative Valuation
UPB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, UPB is overvalued; if below, it's undervalued.
Historical Valuation
Upstream Bio Inc (UPB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.47. The fair price of Upstream Bio Inc (UPB) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：27.70
Fair
-9.00
PE
1Y
3Y
5Y
Trailing
Forward
-6.20
EV/EBITDA
Upstream Bio Inc. (UPB) has a current EV/EBITDA of -6.20. The 5-year average EV/EBITDA is -4.03. The thresholds are as follows: Strongly Undervalued below -11.47, Undervalued between -11.47 and -7.75, Fairly Valued between -0.30 and -7.75, Overvalued between -0.30 and 3.42, and Strongly Overvalued above 3.42. The current Forward EV/EBITDA of -6.20 falls within the Historic Trend Line -Fairly Valued range.
-5.30
EV/EBIT
Upstream Bio Inc. (UPB) has a current EV/EBIT of -5.30. The 5-year average EV/EBIT is -3.57. The thresholds are as follows: Strongly Undervalued below -10.10, Undervalued between -10.10 and -6.83, Fairly Valued between -0.30 and -6.83, Overvalued between -0.30 and 2.96, and Strongly Overvalued above 2.96. The current Forward EV/EBIT of -5.30 falls within the Historic Trend Line -Fairly Valued range.
1439.00
PS
Upstream Bio Inc. (UPB) has a current PS of 1439.00. The 5-year average PS is 536.84. The thresholds are as follows: Strongly Undervalued below -179.61, Undervalued between -179.61 and 178.62, Fairly Valued between 895.07 and 178.62, Overvalued between 895.07 and 1253.29, and Strongly Overvalued above 1253.29. The current Forward PS of 1439.00 falls within the Strongly Overvalued range.
-10.77
P/OCF
Upstream Bio Inc. (UPB) has a current P/OCF of -10.77. The 5-year average P/OCF is -7.10. The thresholds are as follows: Strongly Undervalued below -14.05, Undervalued between -14.05 and -10.58, Fairly Valued between -3.63 and -10.58, Overvalued between -3.63 and -0.15, and Strongly Overvalued above -0.15. The current Forward P/OCF of -10.77 falls within the Undervalued range.
-12.98
P/FCF
Upstream Bio Inc. (UPB) has a current P/FCF of -12.98. The 5-year average P/FCF is -11.77. The thresholds are as follows: Strongly Undervalued below -23.91, Undervalued between -23.91 and -17.84, Fairly Valued between -5.70 and -17.84, Overvalued between -5.70 and 0.37, and Strongly Overvalued above 0.37. The current Forward P/FCF of -12.98 falls within the Historic Trend Line -Fairly Valued range.
Upstream Bio Inc (UPB) has a current Price-to-Book (P/B) ratio of 3.85. Compared to its 3-year average P/B ratio of 1.17 , the current P/B ratio is approximately 228.79% higher. Relative to its 5-year average P/B ratio of 1.17, the current P/B ratio is about 228.79% higher. Upstream Bio Inc (UPB) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -11.43%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -11.43% , the current FCF yield is about -100.00% lower.
3.96
P/B
Median3y
1.17
Median5y
1.17
-8.41
FCF Yield
Median3y
-11.43
Median5y
-11.43
Competitors Valuation Multiple
The average P/S ratio for UPB's competitors is 0.00, providing a benchmark for relative valuation. Upstream Bio Inc Corp (UPB) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 12.52%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of UPB increased by 68.73% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -2.63K to -4.94K.
The secondary factor is the Revenue Growth, contributed 12.52%to the performance.
Overall, the performance of UPB in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Upstream Bio Inc (UPB) currently overvalued or undervalued?
What is Upstream Bio Inc (UPB) fair value?
How does UPB's valuation metrics compare to the industry average?
What is the current P/B ratio for Upstream Bio Inc (UPB) as of Dec 05 2025?
What is the current FCF Yield for Upstream Bio Inc (UPB) as of Dec 05 2025?
What is the current Forward P/E ratio for Upstream Bio Inc (UPB) as of Dec 05 2025?